Zynerba Pharmaceuticals Aktie

Kaufen
Verkaufen
Aktien, ETFs, Sparpläne & Kryptos zu Top-Konditionen beim Testsieger von finanztip.de handeln! Bei einem anderen Broker handeln Smartphone
Div. Rendite 0,00%

WKN A14XCV

ISIN US98986X1090

Symbol ZYNE


Zynerba Pharmaceuticals Aktie Analyse

22.04.19 Zynerba Pharmaceuticals Buy Canaccord Adams
01.02.18 Zynerba Pharmaceuticals Buy H.C. Wainwright & Co.
26.01.18 Zynerba Pharmaceuticals Buy Seaport Global Securities
02.10.17 Zynerba Pharmaceuticals Overweight Cantor Fitzgerald
08.08.17 Zynerba Pharmaceuticals Neutral H.C. Wainwright & Co.
07.08.17 Zynerba Pharmaceuticals Hold Maxim Group
07.08.17 Zynerba Pharmaceuticals Neutral Cantor Fitzgerald
28.03.17 Zynerba Pharmaceuticals Buy H.C. Wainwright & Co.
24.02.17 Zynerba Pharmaceuticals Buy Maxim Group
22.12.16 Zynerba Pharmaceuticals Overweight Cantor Fitzgerald
07.10.16 Zynerba Pharmaceuticals Buy H.C. Wainwright & Co.
12.11.15 Zynerba Pharmaceuticals Outperform Oppenheimer & Co. Inc.
08.09.15 Zynerba Pharmaceuticals Outperform Oppenheimer & Co. Inc.